Francisco Vera-Badillo

Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer

Ian D. Davis, Andrew Martin, Martin R. Stockler et al. · New England Journal of Medicine · 2019 · 1.6K citations

Pharmacy, Oncology, Pharmacotherapy +17

Impact of Spin in the Abstracts of Articles Reporting Results of Randomized Controlled Trials in the Field of Cancer: The SPIIN Randomized Controlled Trial

Isabelle Boutron, Douglas G. Altman, Sally Hopewell et al. · Journal of Clinical Oncology · 2014 · 357 citations · Full text

Public Health, Oncology, Experimental Design +11

Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer

Kim N., Dana E. Rathkopf, Matthew R. Smith et al. · Journal of Clinical Oncology · 2023 · 319 citations · Full text

Medicine, Oncology, Urology +17

Simple prognostic score for metastatic castration‐resistant prostate cancer with incorporation of neutrophil‐to‐lymphocyte ratio

Arnoud J. Templeton, Carmel Pezaro, Aurelius Omlin et al. · Cancer · 2014 · 145 citations · Full text

Medicine, Biostatistics, Oncology +17

Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trials

Robert J. van Soest, Arnoud J. Templeton, Francisco Vera-Badillo et al. · Annals of Oncology · 2014 · 141 citations · Full text

Medicine, Immunology, Oncology +17